VISION:
We seek a world where neurodegenerative diseases can be cured or prevented.
We want that with our research we contribute to discover new effective treatments for these devastating diseases, and even prevent them.
MISSION:
To understand the complex causes of neurodegenerative diseases, and decipher what there is in each person’s particular life that makes them more susceptible to suffering from one disease or another.
VALUES:
Neuroscience & Outreach ⏱️ 3 min read • 📍 Madrid (UCM) Are you a passionate bioinformatician or geneticist driven to decode the molecular secrets of
Neuroscience & Outreach ⏱️ 3 min read • 📍 Madrid (UCM) At Scorrochano Lab, we are celebrating a truly inspiring academic and scientific milestone! With
Neuroscience & Outreach ⏱️ 3 min read • 📍 Madrid (UCM) At Scorrochano Lab, we are celebrating a year filled with discovery, perseverance, and scientific
Neuroscience & Outreach ⏱️ 3 min read • 📍 Madrid (UCM) Young talent and technological innovation are the engine driving Scorrochano Lab! Today we celebrate
Neuroscience & Outreach ⏱️ 3 min read • 📍 Madrid (UCM) Scientific excellence and pride are at an all-time high at Scorrochano Lab! The Nova
Neuroscience & Outreach ⏱️ 3 min read • 📍 Madrid (UCM) At Scorrochano Lab, science never stops, and there is no greater celebration than welcoming
Our lab investigates neurodegenerative diseases like Alzheimer’s, ALS, and frontotemporal dementia, focusing on their multifaceted causes and systemic impacts, including effects on metabolism and lifestyle factors. We adopt a holistic, multifactorial strategy in our research, integrating multi-omics and personalized medicine to develop tailored patient solutions.
We have three main ongoing research lines:
These collaborations involve sharing resources, knowledge, and expertise to advance understanding and treatment of different medical conditions. Additionally, collaboration between institutions and countries is promoted to enhance the impact of research and foster the exchange of ideas and findings.
– EpilipidNet– CA 18105- Pan European Network in Lipidomics and Epilipidomics. COST-Actions. From 2020- Ongoing.
– EATRIS: the European infrastructure for translational medicine- in the section of patient Biomarkers, with the ALS Unit of the Hospital Clínico San Carlos (from 2020- Ongoing).
– MouseAge – The Cost –Action. (Finished in 2020).
